| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.10T | 4.10T | 3.87T | 3.54T | 2.80T | 2.19T |
| Gross Profit | 627.11B | 1.32T | 1.21T | 1.04T | 779.58B | 581.05B |
| EBITDA | 787.97B | 825.44B | 787.00B | 658.49B | 473.14B | 309.67B |
| Net Income | 402.41B | 439.61B | 393.43B | 326.40B | 224.93B | 106.24B |
Balance Sheet | ||||||
| Total Assets | 6.31T | 5.77T | 5.64T | 4.88T | 4.35T | 3.78T |
| Cash, Cash Equivalents and Short-Term Investments | 429.03B | 385.57B | 403.18B | 294.46B | 316.67B | 243.13B |
| Total Debt | 1.58T | 1.22T | 1.27T | 1.12T | 1.01T | 965.85B |
| Total Liabilities | 2.76T | 2.43T | 2.44T | 2.20T | 1.99T | 1.77T |
| Stockholders Equity | 3.36T | 3.17T | 3.03T | 2.54T | 2.23T | 1.91T |
Cash Flow | ||||||
| Free Cash Flow | 247.37B | 311.31B | 231.83B | 22.94B | 138.01B | 172.58B |
| Operating Cash Flow | 469.53B | 517.17B | 434.78B | 206.47B | 300.97B | 354.13B |
| Investing Cash Flow | -95.95B | -210.67B | -204.42B | -169.52B | -143.57B | -163.06B |
| Financing Cash Flow | -171.79B | -321.42B | -122.04B | -66.61B | -93.87B | -199.67B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | $316.81B | 30.12 | 45.10% | 0.98% | -1.51% | -9.69% | |
73 Outperform | $159.30B | 54.83 | 19.74% | 1.34% | -11.66% | -27.80% | |
72 Outperform | $63.33B | 24.25 | 12.57% | 3.83% | -15.29% | -42.93% | |
68 Neutral | $40.79B | 11.75 | 12.42% | 4.03% | 0.99% | 9.08% | |
66 Neutral | $8.97B | 10.68 | 17.36% | 1.10% | -20.09% | 121.28% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
59 Neutral | $13.84B | 22.56 | 6.58% | 2.67% | -18.10% | -65.24% |